With the global prevalence of diabetes escalating, traditional blood glucose monitoring technologies are constrained by inadequate precision, discontinuous monitoring, and inefficient clinical collaboration. This paper focuses on the “Hengtang Zhihang” intelligent non-invasive blood glucose management system, which is developed based on China’s pioneering third-generation glucose sensing technology. It systematically analyzes the system’s integrated solution covering hardware, software, and clinical services, and comprehensively compares its advantages over traditional methods such as capillary blood glucose monitoring and conventional continuous glucose monitoring. Clinical application data from a tertiary hospital in Shanghai verifies that the system significantly reduces diabetes-related complications and improves the operational efficiency of medical institutions. Additionally, this paper explores the system’s market-oriented operation path and technological iteration direction. The research findings provide valuable references for promoting the innovation and development of diabetes monitoring technology and advancing the localization of high-end medical devices in China.